103 related articles for article (PubMed ID: 38686653)
1. Autophagy-related CMTM6 promotes glioblastoma progression by activating Wnt/β-catenin pathway and acts as an onco-immunological biomarker.
Dai L; Xiao J; Li X; Tao Y; Zhou P; Lyu L; Shi Z; Liang X; Jia Z; Jiang S
J Gene Med; 2024 May; 26(5):e3685. PubMed ID: 38686653
[TBL] [Abstract][Full Text] [Related]
2. The mitochondria-related gene risk mode revealed p66Shc as a prognostic mitochondria-related gene of glioblastoma.
Peng G; Feng Y; Wang X; Huang W; Li Y
Sci Rep; 2024 May; 14(1):11418. PubMed ID: 38763954
[TBL] [Abstract][Full Text] [Related]
3. CST2 promotes cell proliferation and regulates cell cycle by activating Wnt-β-catenin signalling pathway in serous ovarian cancer.
Wang X; Zhao S; Guo Y; Wang C; Han S; Wang X
J Obstet Gynaecol; 2024 Dec; 44(1):2363515. PubMed ID: 38864487
[TBL] [Abstract][Full Text] [Related]
4. COL8A1 is a potential prognostic biomarker associated with migration, proliferation, and tumor microenvironment in glioma.
Liu M; Liang W; Su Y; Wen Y; Qi J; Wang L; Su S; Zhao J; Shan J; Wang J
Exp Cell Res; 2024 Jun; 439(1):114076. PubMed ID: 38719174
[TBL] [Abstract][Full Text] [Related]
5. PL-hMSC and CH-hMSC derived soluble factors inhibit proliferation but improve hGBM cell migration by activating TGF-β and inhibiting Wnt signaling.
Uthanaphun T; Manochantr S; Tantrawatpan C; Tantikanlayaporn D; Kheolamai P
Biosci Rep; 2024 May; 44(5):. PubMed ID: 38687607
[TBL] [Abstract][Full Text] [Related]
6. SRSF9 promotes cell proliferation and migration of glioblastoma through enhancing CDK1 expression.
Luo C; He J; Yang Y; Wu K; Fu X; Cheng J; Ming Y; Liu W; Peng Y
J Cancer Res Clin Oncol; 2024 Jun; 150(6):292. PubMed ID: 38842611
[TBL] [Abstract][Full Text] [Related]
7. Copy number gain of FAM131B-AS2 promotes the progression of glioblastoma by mitigating replication stress.
Wang S; Qi Y; Zhao R; Pan Z; Li B; Qiu W; Zhao S; Guo X; Ni S; Li G; Xue H
Neuro Oncol; 2024 Jun; 26(6):1027-1041. PubMed ID: 38285005
[TBL] [Abstract][Full Text] [Related]
8. Identification and validation of the role of ZNF281 in 5-fluorouracil chemotherapy of gastric cancer.
Li Y; Zhou C; Wang G; Xin H; Xiao Y; Qin C
J Cancer Res Clin Oncol; 2024 Jun; 150(6):307. PubMed ID: 38880820
[TBL] [Abstract][Full Text] [Related]
9. TAK-242 inhibits glioblastoma invasion, migration, and proneural-mesenchymal transition by inhibiting TLR4 signaling.
Feng Z; Chen G; Huang Y; Zhang K; Wu G; Xing W; Wu Y; Zhou Y; Sun C
Exp Cell Res; 2024 Jun; 439(1):114091. PubMed ID: 38740168
[TBL] [Abstract][Full Text] [Related]
10. Endosome associated trafficking regulator 1 promotes tumor growth and invasion of glioblastoma multiforme via inhibiting TNF signaling pathway.
Zhang Q; Dai Z; Chen Y; Li Q; Guo Y; Zhu Z; Tu M; Cai L; Lu X
J Neurooncol; 2024 Jan; 166(1):113-127. PubMed ID: 38191954
[TBL] [Abstract][Full Text] [Related]
11. PARG Promotes Esophagus Cancer Cell Metastasis by Activation of the Wnt/β-Catenin Pathway.
Yan J; Zhou Y; Wang Y; Liu Y
Biochem Genet; 2024 Apr; 62(2):761-774. PubMed ID: 37429965
[TBL] [Abstract][Full Text] [Related]
12. Unveiling novel cell clusters and biomarkers in glioblastoma and its peritumoral microenvironment at the single-cell perspective.
Wang L; Li X; Xu C; Wang D; Ma C; Wang Z; Li Y; Li Z
J Transl Med; 2024 Jun; 22(1):551. PubMed ID: 38851695
[TBL] [Abstract][Full Text] [Related]
13. CMTM6 shapes antitumor T cell response through modulating protein expression of CD58 and PD-L1.
Miao B; Hu Z; Mezzadra R; Hoeijmakers L; Fauster A; Du S; Yang Z; Sator-Schmitt M; Engel H; Li X; Broderick C; Jin G; Gomez-Eerland R; Rozeman L; Lei X; Matsuo H; Yang C; Hofland I; Peters D; Broeks A; Laport E; Fitz A; Zhao X; Mahmoud MAA; Ma X; Sander S; Liu HK; Cui G; Gan Y; Wu W; Xiao Y; Heck AJR; Guan W; Lowe SW; Horlings HM; Wang C; Brummelkamp TR; Blank CU; Schumacher TNM; Sun C
Cancer Cell; 2023 Oct; 41(10):1817-1828.e9. PubMed ID: 37683639
[TBL] [Abstract][Full Text] [Related]
14. Upregulation of HLA-II related to LAG-3
Guo W; Peng D; Liao Y; Lou L; Guo M; Li C; Yu W; Tian X; Wang G; Lv P; Zuo J; Shen H; Li Y
Cancer Sci; 2024 May; 115(5):1388-1404. PubMed ID: 38480275
[TBL] [Abstract][Full Text] [Related]
15. Gelsolin knockdown confers radiosensitivity to glioblastoma cells.
Gao D; Jiang T; Liu Y
Cancer Med; 2024 May; 13(10):e7286. PubMed ID: 38803199
[TBL] [Abstract][Full Text] [Related]
16. Sesamolin serves as an MYH14 inhibitor to sensitize endometrial cancer to chemotherapy and endocrine therapy via suppressing MYH9/GSK3β/β-catenin signaling.
Lin Y; Chen X; Lin L; Xu B; Zhu X; Lin X
Cell Mol Biol Lett; 2024 May; 29(1):63. PubMed ID: 38698330
[TBL] [Abstract][Full Text] [Related]
17. EMR-3: a potential mediator of invasive phenotypic variation in glioblastoma and novel therapeutic target.
Kane AJ; Sughrue ME; Rutkowski MJ; Phillips JJ; Parsa AT
Neuroreport; 2010 Nov; 21(16):1018-22. PubMed ID: 20827226
[TBL] [Abstract][Full Text] [Related]
18. Immune cell infiltration and inflammatory landscape in primary brain tumours.
Luce A; Abate M; Scognamiglio G; Montella M; Iervolino D; Campione S; Di Mauro A; Sepe O; Gigantino V; Tathode MS; Ferrara G; Monaco R; De Dominicis G; Misso G; Gentile V; Franco R; Zappavigna S; Caraglia M
J Transl Med; 2024 May; 22(1):521. PubMed ID: 38816839
[TBL] [Abstract][Full Text] [Related]
19. Lysine Methyltransferase 5A Promotes the Progression of Growth Hormone Pituitary Neuroendocrine Tumors through the Wnt/β-Catenin Signaling Pathway.
Li J; Song H; Chen T; Zhang S; Zhang C; Ma C; Zhang L; Wang T; Qian Y; Deng X
Neuroendocrinology; 2024; 114(6):589-601. PubMed ID: 38565081
[TBL] [Abstract][Full Text] [Related]
20. WDR1 promotes prostate cancer progression through Wnt/β-catenin signaling.
Cheng J; Huo D; Zhang Z; Zhang J; Dong B; Liu Z; Zhou Z; Lu Y
Med Oncol; 2024 May; 41(6):151. PubMed ID: 38743149
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
